Cytology is a branch of pathology that deals with the study of
physical, chemical, and functional characters of cells. Cytology is
one of the leading diagnostic methods used for detection of cancer.
Cytology collection involves extracting cells from various body parts
by using specialized devices. These specimens are further processed
by cytology testing devices in pathology laboratories to evaluate the
presence of a disease. Cytology specimens are collected from body
parts such as the oral cavity, the gastrointestinal tract, the
cervical tract, and the respiratory tract and from plural fluid,
pericardial fluid, and spinal fluid. Most of the cytology collection
techniques are non-invasive; however, some apply invasive or surgical
techniques to collect the specimen. Selection of the cytology device
depends on the application area and specimen requirements.
Report Overview @
https://www.transparencymarketresearch.com/cytology-devices-market.html
Cancer detection is one of the widely applied areas of cytology.
According to the World Health Organization (WHO), 14 million new
cancer cases were diagnosed in 2012 and the number of new cases is
estimated to rise by 70% by 2035. High prevalence of cancer across
the globe is estimated to increase the adoption of cytology devices
for conducting cytology tests. Technical advancements in the field of
cytology such as automated cytology analyzers and point-of-care
testing devices are estimated to fuel the cytology devices market
during the forecast period. Increasing efficiency and availability of
advanced collection devices such as aspiration needles for collection
of liver and pancreas specimens is projected to propel the cytology
devices market from 2017 to 2025.
However, availability of
low-quality and inexpensive cytology devices in regional marketplaces
is anticipated to hamper the cytology devices market. Moreover,
developments in alternative therapies such as immunoassays and
molecular diagnostics is likely to hamper the market from 2017 to
2025.
The global cytology devices market can be segmented based on product,
application, end-user, and region. In terms of product, the market
can be divided into brushes, spatulas, aspiration needles, and
others. The brushes segment can be sub-divided into metallic and
plastic brushes. The others segment comprises cytology devices such
as currets and cervical brooms. The brushes segment is anticipated to
hold a leading share of the global cytology devices market from 2017
to 2025. The aspiration needles segment is anticipated to witness
high growth during the forecast period, owing to their rising usage
in the collection of liver, pancreas, and breast specimens as well as
plural fluids and spinal fluids.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36158
Based on application, the global cytology devices market can be
segmented into pulmonology, gastroenterology, gynecology, and others.
High prevalence of cervical cancer and launch of new products for the
treatment of cervical cancer are factors estimated to fuel the
gynecology segment during the forecast period. Technological
advancements in the field of gastroenterology such as new endoscopy
systems and ultrasound endoscopy are projected to contribute to high
growth of the gastroenterology segment. Based on end-user, the market
can be segmented into hospitals, ambulatory surgical centers,
diagnostic laboratories, and others. The diagnostic laboratories
segment is likely to account for a leading share of the global
cytology devices market during the forecast period.
Geographically, the global cytology devices market can be segmented
into North America, Europe, Asia Pacific, Latin America, and Middle
East & Africa. North America is estimated to constitute a leading
share of the global market during the forecast period, owing to high
number of cytology tests being performed in the region. Europe is
anticipated to account for a significant share of the global market
between 2017 and 2025. According to the World Health Organization
(WHO), around 3.7 million new cases of cancer were registered in
Europe in 2012. The market in Asia Pacific is projected to witness
high growth during the forecast period, owing to increasing health
care expenditure in the region.
Major players operating in the global cytology devices market are
Biocytech Corporation, RI.MOS. srl, CONMED Corporation, Olympus
Corporation, MEDI-GLOBE CORPORATION, US Endoscopy (a part of STERIS
Corporation), ENDO-FLEX GmbH, Nipro, and STERYLAB S.r.l.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=36158<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment